SILO Silo Pharma, Inc. - 8-K

Item 3.03. Material Modification to Rights of Security Holders.

To the extent required
by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this report is incorporated herein by reference.

Item 5.03 Amendments
to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On June 1, 2026, Silo
Pharma, Inc. (the “Company”) filed a Certificate of Change (the “Certificate of Change”) with the Secretary of
State of the State of Nevada to effectuate a 1-for-15 reverse stock split (the “Reverse Stock Split”) of the Company’s
issued and outstanding and authorized shares of common stock, par value $0.0001 per share (“Common Stock”). The Reverse Stock
Split became effective at 4:01 p.m., Eastern Time, on Tuesday, June 2, 2026, and the Company’s Common Stock began trading on a split-adjusted
basis when The Nasdaq Stock Market (“Nasdaq”) opened on June 3, 2026.

When the Reverse Stock
Split became effective, every 15 shares of Common Stock issued and outstanding were automatically reclassified and combined into one share
of Common Stock, without any change in the par value per share, and a proportionate reduction was made to the Company’s authorized
shares of Common Stock such that the Company now has 6,666,667 shares of authorized Common Stock. In addition, a proportionate adjustment
has been made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding stock options and
warrants to purchase shares of Common Stock and the number of shares reserved for issuance pursuant to the Company’s equity incentive
compensation plans. No fractional shares of Common Stock were issued in connection with the Reverse Stock Split. Stockholders who otherwise
would have been entitled to receive fractional shares of Common Stock had their holdings rounded up to the next whole share.

The Company’s Common
Stock will continue to trade on The Nasdaq Capital Market under the existing symbol “SILO”, but the security has been assigned
a new CUSIP number (82711P 300).

The foregoing description
of the Certificate of Change does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate
of Change which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 8.01. Other Events.

The information contained
in Item 5.03 of this report is incorporated herein by reference.

The Company has a registration
statements on Form S-1 (File Nos. 333-280855 and 333-291129) and a registration statements on Form S-3 (File Nos. 333-276658) on file
with the SEC. SEC regulations permit the Company to incorporate by reference future filings made with the SEC pursuant to Sections 13(a),
13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, prior to the termination of the offerings covered by registration
statements filed on Form S-3 or Form S-8. The information incorporated by reference is considered to be part of the prospectus included
within each of those registration statements. Information in this Item 8.01 of this report is therefore intended to be automatically incorporated
by reference into each of the active registration statements listed above, thereby amending them. Pursuant to Rule 416(b) under the Securities
Act of 1933, as amended, the amount of undistributed shares of Common Stock deemed to be covered by the effective registration statements
of the Company described above are proportionately reduced as of the effective time of the Reverse Stock Split at the 1-15 Reverse Stock
Split ratio, giving effect to the Reverse Stock Split.

Item 9.01 Financial
Statements and Exhibits.

(d)  Exhibits

Exhibit

Description

3.1

Certificate of Change

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

1